The South Korea membrane filters market size is projected to reach US$ 186.20 million by 2031 from US$ 70.15 million in 2023. The market is expected to register a CAGR of 13.0% during 2023–2031. Technological advancements in membrane filtration are likely to bring new trends in the market during the forecast period.
Increasing demand for advanced filtration technologies across various industries, including pharmaceuticals, contributes to the market growth. In addition, rising concerns over water quality and the need for efficient filtration systems to meet stringent regulatory standards are major factors fueling the market growth. Additionally, the booming pharmaceutical and biopharmaceutical sectors in South Korea require high-quality membrane filters for processes such as drug manufacturing, biotechnology research, and sterile filtration. Technological advancements in membrane materials and the growing focus on sustainable filtration solutions further support the market expansion in South Korea.
Membrane filtration plays a vital role in sterilization, separation, and purification processes, ensuring high standards of quality and safety. Advancements in filtration technologies and increasing demand across various industries are contributing to the market expansion. In pharmaceuticals and biotechnology industries, membrane filters are essential for sterile filtration, drug production, and bioprocessing, which help maintain product integrity. Additionally, the growing emphasis on water quality and sustainability is boosting the demand for filtration systems in water and wastewater treatment. Technological advancements in durable, high-performance membrane materials are enhancing efficiency, which is likely to create opportunities for the market players in the coming years. As regulatory standards become stricter, the need for reliable and efficient filtration solutions will continue to drive the growth of the membrane filters market in the country.
The growing demand for sterile and contaminant-free products in pharmaceutical and biotechnology industries drives the South Korea membrane filters market. In South Korea, the biopharmaceutical sector is increasingly adopting stringent quality control standards and a strict regulatory framework established by the Ministry of Food and Drug Safety (MFDS) for the production of biologics, vaccines, and sterile injectable drugs, which elevates the need for advanced filtration technologies. As the primary regulatory authority for pharmaceuticals, biologics, and medical devices in the country, the MFDS enforces regulations that align with international standards. This ensures that products adhere to stringent quality control measures, guaranteeing their safety, efficacy, and sterility. As South Korea leads in vaccine production and gene therapy development, membrane filtration plays a vital role in ensuring the quality and safety of these high-value therapies. For instance, during the production of COVID-19 vaccines, sterile filtration technologies were employed to eliminate impurities and maintain the integrity of the vaccine.
The rapid growth of the pharmaceutical and biopharmaceutical sectors is expected to create significant opportunities for the South Korea membrane filters market during the forecast period. According to the Observatory of Economic Complexity (OEC), South Korea exported US$ 8.78 billion in pharmaceutical products in 2022, making it the 20th largest exporter of such products in the world. Furthermore, in the same year, pharmaceutical products ranked as the 12th most exported product from South Korea. Additionally, between September 2023 and September 2024, exports of South Korea's pharmaceutical products increased by US$ 148 million (27.4%), rising from US$ 539 million to US$ 687 million. This expansion is driven by increasing demand for biologics, vaccines, and high-quality pharmaceutical products, all of which require advanced filtration technologies for production and purification processes.
Membrane filters play a crucial role in ensuring the sterility and purity of biologics and vaccines. These filters are used in critical stages such as the filtration of cell cultures, virus removal, and sterilization of injectable drugs. Leading biopharmaceutical companies such as Samsung Biologics and Celltrion are at the forefront of this expansion, necessitating the adoption of advanced membrane filtration solutions to meet stringent regulatory standards and maintain product quality. For instance, according to Invest KOREA, South Korea is enhancing its reputation as a global biopharmaceutical production hub. In 2022, Samsung Biologics produced 424,000 liters, achieving the world's largest consignment production capacity, and plans to increase this capacity by an additional 360,000 liters by 2026.
The key segments that contributed to the derivation of the South Korea membrane filters market analysis are technology, design, material, and end users.
The expansion of the pharmaceutical and biopharmaceutical sectors in South Korea drives the market. In April 2024, Wood, a global leader in consulting and engineering, collaborated with Celltrion, a prominent biopharmaceutical company, to expand its biopharma manufacturing hub in Songdo, Incheon, South Korea. As part of this contract, Wood will deliver a detailed engineering design for a new facility to enhance the manufacturing capacity of biological medicines by 8 million liquid vials per year. This expansion project aims to meet the growing demand for biopharmaceutical drug products. By supporting Celltrion in expanding its product pipeline and securing manufacturing capacity, Wood’s advanced process engineering design capabilities will help improve production efficiency and minimize downtime when transitioning equipment between different products. This will ultimately lead to operational cost savings for the facility.
The regional trends and factors influencing the South Korea Membrane Filters Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses South Korea Membrane Filters Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 70.15 Million |
Market Size by 2031 | US$ 186.20 Million |
Global CAGR (2023 - 2031) | 13.0% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Technology
|
Regions and Countries Covered | South Korea
|
Market leaders and key company profiles |
The South Korea Membrane Filters Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the South Korea Membrane Filters Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The “South Korea Membrane Filters Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
The List of Companies - South Korea Membrane Filters Market
The South Korea membrane filters market is estimated to register a CAGR of 13.0% from 2023 to 2031.
The value of the South Korea membrane filters market is estimated to reach US$ 186.20 million by 2031.
Danaher, VEOLIA, 3M Healthcare, PENTAIR, TORAY, KOCH SEPARATION SOLUTIONS, Merck KGaA, Sartorius AG, Thermo Fisher Scientific, Inc., and Repligen are among the key market players in the South Korea membrane filters market.
The increasing demand for sterile and contaminant-free products and rising prevalence of chronic diseases are the most influential factors responsible for the market growth.